🟢 Beam Therapeutics Inc is trading 4% up today as markets rebound from macro-driven selling

Beam Therapeutics Inc is trading 4% up at $30.97 in early session trading, rebounding modestly after recent double-digit swings over the past week.

• The move follows broader risk-on sentiment after U.S. markets bounced on June 8, 2026, from prior macro-driven selling.
• No fresh company-specific headlines or analyst calls have hit major wires this morning.
• Traders may be bottom-fishing after last week’s steep biotech volatility.